2014
DOI: 10.1016/j.colsurfb.2014.01.004
|View full text |Cite
|
Sign up to set email alerts
|

pH and glutathion-responsive hydrogel for localized delivery of paclitaxel

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
31
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 33 publications
(36 citation statements)
references
References 39 publications
5
31
0
Order By: Relevance
“…Despite the success of novel strategies such as soluble derivatives or prodrugs, [1][2][3] the strategy using a delivery system is still a predominant approach, particularly considering its potential to achieve targeted delivery or codelivery of different components. [4][5][6] In recent years, various types of materials have been investigated as delivery systems for hydrophobic drugs, including, but not limited to, liposomes, 7 polymeric nanoparticles, [8][9][10] hydrogels, 11,12 and carbon nanotubes. [13][14][15] Several wellstudied materials have been developed into clinically available formulations, such as Abraxane ® and Doxil ® .…”
Section: Introductionmentioning
confidence: 99%
“…Despite the success of novel strategies such as soluble derivatives or prodrugs, [1][2][3] the strategy using a delivery system is still a predominant approach, particularly considering its potential to achieve targeted delivery or codelivery of different components. [4][5][6] In recent years, various types of materials have been investigated as delivery systems for hydrophobic drugs, including, but not limited to, liposomes, 7 polymeric nanoparticles, [8][9][10] hydrogels, 11,12 and carbon nanotubes. [13][14][15] Several wellstudied materials have been developed into clinically available formulations, such as Abraxane ® and Doxil ® .…”
Section: Introductionmentioning
confidence: 99%
“…Perez et al [115] formulated a pH and glutathion-responsive, PTX-loaded poly- N -isopropylacrylamide (NIPA), tert-butyl 2-acrylamidoethyl carbamate (2AAECM) and N -hydroxyethyl acrylamide (HEAA)-based nanohydrogel by a microemulsion polymerization method comprising N , N '-cystaminebisacrylamide (CBA) as crosslinker. The developed formulations were assessed for cytotoxicity and cellular uptake studies using MTT assay and Coumarin-6, respectively, against cancer cell lines (MCF-7, T47D, and HeLa).…”
Section: Localized Drug Delivery Systemsmentioning
confidence: 99%
“…In vitro characterisation of these stimuli-responsive NG revealed a nanometre size in the swollen state and good cytocompatibility in studies conducted with different tumour cell lines (MCF7, HeLa and T47D). Moreover, nanosystems containing disulphide linkages in their network composition, such as the CBA cross-linking agent, demonstrated a bioreducible response when they were in contact with reducing intracellular medium conditions [19]. In contrast, nanohydrogels containing NMBA did not show that redox response, as this crosslinking-agent provided more stable network particles [20].…”
Section: Introductionmentioning
confidence: 97%
“…In our previous works, new stimuli-responsive nanohydrogels (NG) based on poly-N-isopropylacrylamide (NIPA), N-hydroxyethyl acrylamide (HEAA) and tert-butyl 2-acrylamidoethyl carbamate (2AAECM) were synthesised by a microemulsion polymerisation method using two different crosslinking agents: N, N-cystaminebisacrylamide (CBA) [19] and Nmethylenebisacrylamide (NMBA) [20]. In vitro characterisation of these stimuli-responsive NG revealed a nanometre size in the swollen state and good cytocompatibility in studies conducted with different tumour cell lines (MCF7, HeLa and T47D).…”
Section: Introductionmentioning
confidence: 99%